Vidalta 15 mg prolonged-release tablets for cats
Vidalta 15 mg prolonged-release tablets for cats
Not authorised
- Carbimazole
Product identification
Medicine name:
Vidalta 15 mg prolonged-release tablets for cats
Vidalta Vet 15 mg Comprimé à libération prolongée
Active substance:
- Carbimazole
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Carbimazole15.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03BB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Luxembourg
Package description:
- High density polyethylene container of 100 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
- High density polyethylene container of 30 closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet Ges.m.b.H.
Responsible authority:
- Le Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V817/12/05/1192
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0442/002
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
French (PDF)
Published on: 20/06/2022
How useful was this page?:
